The NIH’s growing emphasis on New Approach Methodologies (NAMs) marks a significant change in how biomedical research, particularly drug development, is being conducted. Prompted by legislative changes, evolving regulatory guidance, and long-standing concerns about the ethics and limits of animal models, NAMs are increasingly being used to study drug safety, pharmacology, and biological mechanisms using […]
In a rapidly evolving healthcare landscape, staying ahead in the field of in vitro diagnostics (IVD) is more crucial than ever. This blog delves into key insights from Kalorama Information’s latest market research report, In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029. As the fifth installment in Kalorama’s North American IVD […]
Each year, tens of thousands of men succumb to prostate cancer, a disease with an almost 100% survival rate when diagnosed early. According to a recent article by Fortune, rates of prostate cancer, America’s second-deadliest cancer in men, are on the rise. Since 2014, the U.S. has seen a 3% annual increase in diagnoses of […]
In 2023, global liquid biopsy market sales exceeded $1 billion. Projections indicate a substantial growth trajectory, with an anticipated average annual double-digit growth rate over the next several years. By 2028, the market’s growth will reflect significant momentum and rapid expansion during the forecast period. This is according to The Worldwide Market for Liquid Biopsy, […]
One of the most explored applications of molecular diagnostics is oncology, a segment with sales exceeding $6 billion in 2023, according to new data published in Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028, now on sale by leading medical and diagnostic market research firm Kalorama Information. In the report, the oncology segment is […]
The global market for liquid biopsy diagnostic tests reached an estimated $1,267 million ($1.3 billion) in 2022, led by demand for diagnostics in guiding therapeutic decisions. The market is forecast to almost triple over the next several years, approaching $3.9 billion in 2027, according to medical market research firm Kalorama Information in the new report […]
There are over 40 companies active in the $1 billion global market for liquid biopsy diagnostics and monitoring tests. And demand is growing swiftly, at a projected compound annual growth rate (CAGR) of 29.5% over the next five years, as patients, clinicians, and payors increasingly accept liquid biopsy as an alternative or complementary procedure […]
Whether affecting the lungs, colorectal system, stomach, liver, breasts, or other parts of the body, few medical maladies carry the inherent gravitas of cancer. Annually, millions of new cancer cases are diagnosed and millions of cancer linked deaths occur worldwide. Undoubtedly, cancer poses one of the greatest threats to human health globally. This proliferating […]
